Inventor

JIANG YUTONG

US68 patents

⚠️ This page may combine multiple inventors who share the name “JIANG YUTONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

JIANG YUTONG

ARRAY BIOPHARMA INC

Macrocyclic compounds as trk kinase inhibitors

Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds

Method of treatment using substituted pyrazolo[1,5-a]pyrimidine compounds

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Macrocyclic compounds as TRK kinase inhibitors

Macrocyclic compounds as TRK kinase inhibitors

Macrocyclic compounds as Trk kinase inhibitors

Macrocyclic compounds as Trk kinase inhibitors

Method of treatment using substituted pyrazolo[1,5-A] pyrimidine compounds

Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds

Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds

Method of treatment using substituted imidazo[1,2b]pyridazine compounds

Method of treatment using substituted imidazo[1,2b]pyridazine compounds

Method of treatment using substituted pyrazolo[1,5-a]pyrimidine compounds

Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors

Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors

Substituted pyrazolo [1,5-A] pyrimidine compounds as TRK kinase inhibitors

Crystalline forms

Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors

Macrocyclic compounds as TRK kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Method of treatment using substituted imidazo[1,2b]pyridazine compounds

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors

Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Protein tyrosine phosphatase inhibitors

Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds

Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-A]pyrazine compounds as ret kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-a]pyrazines as RET kinase inhibitors

ALLEN SHELLEY

Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors

Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors

INTERMUNE INC

Macrocyclic compounds as inhibitors of viral replication

Macrocyclic inhibitors of hepatitis C virus replication

HAAS JULIA

Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors

ANDREWS STEVEN D

Substituted imidazo[1,2b]pyridazine compounds as Trk kinase inhibitors

ANDREWS STEVEN WADE

Macrocyclic compounds as Trk kinase inhibitors

BLATT LAWRENCE M

Macrocyclic inhibitors of hepatitis C virus replication

ANDREWS STEVEN W

Method of treatment using substituted imidazo[1,2B]pyridazine compounds